# $vnda

Vanda Pharmaceuticals ($VNDA) is highlighted in upcoming FDA decisions for February, with Bysanti for bipolar I disorder and schizophrenia on the radar. Investor interest in the biotech sector remains high, with $VNDA mentioned alongside other key players facing regulatory reviews.

### About $vnda
Vanda Pharmaceuticals is a biopharmaceutical company focused on developing treatments for central nervous system disorders.  

### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$vnda/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$vnda/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Month: [-------] -54%  
[--] Months: [---------] +409%  
[--] Year: [---------] -45%  
1-Year High: [-------] on 2025-12-31  
1-Year Low: [--] on 2025-09-15  

Engagements by network (24h):
Reddit: [--]
YouTube: [--]
X: [-----]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$vnda/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$vnda/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
1-Year High: [---] on 2025-11-19  
1-Year Low: [--] on 2025-09-14  

Mentions by network (24h):
Reddit: [--]
YouTube: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$vnda/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$vnda/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning $vnda in the last [--] hours which is down 12% from [--] in the previous [--] hours
Daily Average: [--]  
1-Year High: [---] on 2025-11-19  
1-Year Low: [--] on 2025-09-14  

The most influential creators that mention $vnda in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | [--]    | [------]    | [--]     | [-----]       |
| [@OzmosiHealth](/creator/twitter/OzmosiHealth)       | [--]    | [-----]     | [--]     | [---]         |
| [@WolfOfPathogens](/creator/twitter/WolfOfPathogens) | [--]    | [--]         | [--]     | [--]          |
| [@byul_finance](/creator/twitter/byul_finance)       | [--]    | [---]       | [--]     | [--]          |
| [@ElMonoGran42994](/creator/twitter/ElMonoGran42994) | [--]    | [---]       | [--]     | [--]          |
| [@FormalyTwilter](/creator/twitter/FormalyTwilter)   | [--]    | [---]       | [--]     | [--]          |
| [@moneyforfun_](/creator/twitter/moneyforfun_)       | [--]    | [---]       | [--]     | [--]          |
| [@OpenOutcrier](/creator/twitter/OpenOutcrier)       | [--]    | [------]    | [--]     | [--]          |

[View More](/list/creators/$vnda/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$vnda/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$vnda/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 82%  
[--] Month: 62% +18%  
[--] Months: 62% -38%  
[--] Year: 62% -38%  
1-Year High: 100% on 2025-02-14  
1-Year Low: 12% on 2025-11-11  

Most Supportive Themes:
- FDA Decisions: (50%) Vanda Pharmaceuticals is awaiting FDA decisions on its treatments, which are crucial for future drug approvals and market entry.
- Biotech Stock Performance: (50%) Vanda Pharmaceuticals is mentioned in the context of broader biotech stock movements, indicating investor interest in the sector.
  
Most Critical Themes:
  

### Top $vnda Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"#Biotech Stocks Facing FDA Decision In February. $RGNX $VNDA $ETON $ASND $BMRN $XBI https://www.rttnews.com/slideshow/3925/biotech-stocks-facing-fda-decision-in-february-2026.aspxSlide=1 https://www.rttnews.com/slideshow/3925/biotech-stocks-facing-fda-decision-in-february-2026.aspxSlide=1"  
[X Link](https://x.com/BioStocks/status/2017968681750557174) [@BioStocks](/creator/x/BioStocks) 2026-02-01T14:30Z 71.3K followers, [----] engagements


"February Biotech PDUFA Pulse: 📡 Whats on the FDA Radar Feb [--] $RGNX RGX-121 (MPS II / Hunter syndrome) Priority Review Feb [--] $MRK Keytruda (platinum-resistant recurrent ovarian cancer) Priority Review (label expansion) Feb [--] $VNDA Bysanti (bipolar I disorder / schizophrenia) Feb [--] $ETON ET-600 (central diabetes insipidus) Feb [--] $ASND TransCon CNP (achondroplasia) Priority Review Feb [--] $BMRN PALYNZIQ (PKU adolescents) Priority Review (label expansion) See the attached graphic for the full February PDUFA calendar. https://twitter.com/i/web/status/2016215337554083884"  
[X Link](https://x.com/BiopharmIQ/status/2016215337554083884) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-01-27T18:22Z 28.9K followers, 99.7K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing